Skip to content

Opus Genetics IRD Market capitalization

Market capitalization at other companies

AbbVie logo
AbbVieABBV
$384.69B+3.8%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$705.32M+31.9%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$475.29M+218%
Opko Health logo
Opko HealthOPK
$865.34M-22.4%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$2.33B+1,477%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$81.68B+17.8%

Other financials

Income statement

See full
Revenue$2.2M-50.6%
Operating income-$14.4M-44.7%
Net income-$65.5M-700%
EPS (diluted)-$0.75-213%

Balance sheet

See full
Cash & equivalents$60.0M+43.5%
Total debt$1.2M
Total equity-$45.8M-1,004%
Total assets$66.8M+38.7%

Cash flow

See full
Operating cash flow-$12.7M-41.5%

Valuation

See full
Enterprise value$248.38M
P/S25.6×+21.5×

Profitability

See full
Operating margin-359.1%-68.9pp
Net margin-892.4%-12,322pp

Returns & leverage

See full
Return on equity-449.4%-2,573pp
Debt / equity0.1×
Current ratio7.1×+5.2×

Where this comes from

Computed from the period-end share price: $323.73M.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opus Genetics's market capitalization?
Opus Genetics (IRD) reported market capitalization of $323.73M in Q1 2026.
How has Opus Genetics's market capitalization changed year-over-year?
Opus Genetics's market capitalization increased by 633.3% year-over-year, from $44.15M to $323.73M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.